Restriction Spectrum Imaging (RSI) improves cancer detection - Cortechs.ai

Solutions
Our solutions

Advanced AI tools supporting improved diagnosis and monitoring of disease

View all solutions

NeuroQuant®

Best-in-class brain segmentation and volumetric analysis

NeuroQuant® MS

Accurately visualize lesions and lesion volume change.

NeuroAlign CT

Automated CT alignment for fast, accurate diagnosis

NeuroQuant® Brain Tumor

Pre- and post-operative 3D volume analysis of brain tumors.

NeuroQuant® PET

Automated tracer activity quantification

NeuroQuant® ARIA

Segmentation and longitudinal tracking of FLAIR, T2*GRE, and SWI lesions

OnQ™ Prostate

Optimizing prostate MRI for advanced clinical insights.
About
About

We merge state-of-the-art medical imaging with the power of clinical data and machine learning to empower physicians in making more accurate and timely diagnostic decisions.

Learn about Cortechs.ai

Team

The experts behind our industry-leading software and services

Careers

Join the team leading the way in radiology AI applications

Partnerships

The partnerships and strategic alliances behind Cortechs.ai

Events

Meet the Cortechs.ai team in a city near you
Support
Support

Technical and account information for existing Cortechs.ai customers

Find out more

Submit a ticket

Log an issue or query with our service team
Resources
Resources

Discover the latest AI image quantification news in your role or specialism.

Find out more

Case studies

See how Cortechs.ai solutions are elevating patient care

Video Library

View our webinars, user guides and technical specs

Industry news

What you need to know about AI radiology

Cortechs.ai news

The latest headlines from Cortechs.ai

Published research

Evidence-based validation of our impact on neuroimaging

Whitepapers

Read the whitepapers about our solutions

Restriction Spectrum Imaging (RSI) improves cancer detection

November 18, 2023
< 1 mins

Compares the diagnostic performance of restriction spectrum imaging (RSI), with that of conventional multi-parametric (MP) magnetic resonance imaging (MRI) for prostate cancer (PCa) detection in a blinded reader-based format. 2016.

[button]Download[/button]

Topic: Published research

Insights

02/15/2025

NeuroQuant® Dementia: Advancing Alzheimer’s Disease Care in the Era of DMTs

AI-driven brain volumetric analysis is revolutionizing Alzheimer’s care, providing precise diagnostic support, monitoring, and early detection.

Product updates

02/09/2025

NeuroQuant® MS: Advancing Precision in Multiple Sclerosis

Dr. Suzie Bash discusses NeuroQuant MS, noting its ability to segment plaques, analyze volume, and track lesion burden for assessing disease progression

Product updates

02/09/2025

Epilepsy Care with NeuroQuant Seizure: The Power of Quantifying Hippocampal Asymmetry

Accurate imaging of the hippocampus is crucial for effective diagnosis and treatment planning in TLE, with structural abnormalities linked to seizure onset

Product updates